|
Diabetes, Vol 46, Issue 9 1406-1413, Copyright © 1997 by American Diabetes Association
Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver
J Radziuk, Z Zhang, N Wiernsperger and S Pye
Ottawa Civic Hospital and the University of Ottawa, Ontario, Canada.
To directly assess the effects of the biguanide, metformin, on hepatic
gluconeogenesis, it was added at high therapeutic levels (90 microg/ml) to
the medium perfusing an isolated rat liver. Lactate (1 mg/min) was infused
simultaneously along with [14C]lactate with or without [3H]lactate.
[6-(3)H]glucose was added at the beginning of the perfusion in studies
where [3H]lactate was not infused. Glucose levels decreased relative to
control studies (metformin dose = 0) and lactate concentrations increased
in this closed system. Quantitative analysis of the relationship between
labeled glucose and lactate indicated that the flux of carbon from lactate
to glucose and CO2 was halved, whereas reflux from glucose to lactate
increased by approximately 80%. This was corroborated by measurement of
labeled lactate extraction as well as glucose, CO2, and lactate production
across the liver. Glycogen content of the liver fell by 60% relative to
control and was greater for the gluconeogenic pathway. These data are
consistent with an inhibitory action of metformin on gluconeogenesis, which
is due to a primary inhibition of hepatic lactate uptake.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Klein, S. Westphal, D. Kraus, B. Meier, N. Perwitz, V. Ott, M. Fasshauer, and H H. Klein
Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes
J. Endocrinol.,
November 1, 2004;
183(2):
299 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Endocr. Rev.,
October 1, 2004;
25(5):
807 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Brunmair, K. Staniek, F. Gras, N. Scharf, A. Althaym, R. Clara, M. Roden, E. Gnaiger, H. Nohl, W. Waldhausl, et al.
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I: A Common Mechanism Contributing to Their Antidiabetic Actions?
Diabetes,
April 1, 2004;
53(4):
1052 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich
Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity
Diabetes,
June 1, 2003;
52(6):
1386 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Stadtmauer, B. C. Wong, and S. Oehninger
Should patients with polycystic ovary syndrome be treated with metformin?: Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction
Hum. Reprod.,
December 1, 2002;
17(12):
3016 - 3026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Meyer, P. Bohme, I. Delbachian, P. Lehert, N. Cugnardey, P. Drouin, and B. Guerci
The Benefits of Metformin Therapy During Continuous Subcutaneous Insulin Infusion Treatment of Type 1 Diabetic Patients
Diabetes Care,
December 1, 2002;
25(12):
2153 - 2158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers
Metformin: An Update
Ann Intern Med,
July 2, 2002;
137(1):
25 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mithieux, L. Guignot, J.-C. Bordet, and N. Wiernsperger
Intrahepatic Mechanisms Underlying the Effect of Metformin in Decreasing Basal Glucose Production in Rats Fed a High-Fat Diet
Diabetes,
January 1, 2002;
51(1):
139 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang and J. Radziuk
Inverse relationship between peripheral insulin removal and action: studies with metformin
Am J Physiol Endocrinol Metab,
December 1, 2001;
281(6):
E1240 - E1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Song, S. Andrikopoulos, C. Filippis, A. W. Thorburn, D. Khan, and J. Proietto
Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin
Am J Physiol Endocrinol Metab,
August 1, 2001;
281(2):
E275 - E282.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|